by Alex Khadhim
Investigators at the Medical College of Wisconsin, collaborating with microbiome researchers at Memorial Sloan Kettering Cancer Center, have found the addition of the IL-23p19–blocking...
by Alex Khadhim
Researchers at the Fred Hutchinson Cancer Center have found specific donor dendritic cell subsets are dominant drivers of gastrointestinal acute GVHD that can be therapeutically targeted to...
by Alex Khadhim
Researchers at Imperial College London and the University of Oxford have found a bispecific CD19 and CD133 chimeric antigen receptor (CAR) engineered into invariant natural killer T cells can...
by Alex Khadhim
Researchers at Friedrich-Alexander-Universität Erlangen–Nürnberg and Universitätsklinikum Erlangen have found that autologous CD19 CAR T cell therapy can induce rapid, drug-free clinical...
by Clinical Cancer Research
Early research suggests leucine rich repeat containing 15 (LRRC15), which is highly present in osteosarcoma tumors but limited in normal tissues, has potential as a target antigen for chimeric...
by Blood
Experiments with mice and observations in humans justify clinical trial evaluation of pentagastrin as an intervention against acute graft-versus-host disease (aGVHD), researchers report.